BridgeMD
Management of moderate to severe monotraumatic pain with sublingual Sufentanil in an emergency situation.
EU CTIS ID: 2024-519217-64-00
What this study is testing
to determine the efficacy of the use of sublingual sufentanil 30mcg in emergency patients admitted for moderate to severe pain following a single trauma compared to the standard management currently in the department between T0 and T0 + 60 min.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- adult patient
- Patient with a numeric pain rating scale ≥ 4
- Pain of monotraumatic origin in the upper or lower limb
- Glasgow = 15
- SaO2 > 95% in ambient air
You likely can't join if
- Polytrauma
- Patient under guardianship, curatorship, deprived of liberty or under legal protection
- Patient does not speak or read French
- Analgesic treatment within 4 hours prior to admission (except paracetamol)
- Woman of childbearing age not using effective contraception, or declaring herself pregnant or at risk of pregnancy or breastfeeding woman, or positive pregnancy test upon inclusion
- Patient requiring intravenous line placement upon admission
See the full eligibility criteria
- adult patient
- Patient with a numeric pain rating scale ≥ 4
- Pain of monotraumatic origin in the upper or lower limb
- Glasgow = 15
- SaO2 > 95% in ambient air
- Polytrauma
- Patient under guardianship, curatorship, deprived of liberty or under legal protection
- Patient does not speak or read French
- Analgesic treatment within 4 hours prior to admission (except paracetamol)
- Woman of childbearing age not using effective contraception, or declaring herself pregnant or at risk of pregnancy or breastfeeding woman, or positive pregnancy test upon inclusion
- Patient requiring intravenous line placement upon admission
- Contraindication or allergy to one of the molecules in the analgesic protocol
- Refusal to participate
- Known drug abuse or psychiatric disorders
- Known oxygen dependency or COPD
- Not affiliated with social security
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.